Clinical investigation 101
This article was originally published in The Gray Sheet
Executive Summary
Agency's Office of Critical Path Programs will launch a three-day training course for clinical investigators in November, designed to improve the quality and efficiency of trials and improve investigators' understanding of the scientific, ethical and regulatory issues involved in clinical research. Lectures and discussions will be conducted by more than 20 senior staff from FDA's device, drug and biologics centers